EUROPE TUBELESS INSULIN PUMP MARKET

INTRODUCTION

A tubeless insulin pump is a wireless insulin management system that delivers continuous insulin delivery and is connected to the remote utilising Bluetooth connectivity, thereby removing the need for several daily injections. However, the expansion of the business could be significantly impacted by the high long-term costs associated with tubeless insulin pumps and strict governmental requirements. 

As a result, users face serious risks that could be fatal: stopping an insulin infusion can cause hyperglycemia and ketoacidosis, while giving too much insulin can result in severe hypoglycemia. However, there is still little information on the effectiveness and safety of CSII.

EUROPE TUBELESS INSULIN PUMP MARKET SIZE AND FORECAST

The Europe tubeless insulin pump market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

EUROPE TUBELESS INSULIN PUMP MARKETNEW PRODUCT LAUNCH

The first pivotal trials of Insulet Corporation's Omnipod 5 Automated Insulin Delivery System produced encouraging results, the company reported. The world's leading tubeless wearable mechanism that adapts insulin delivery based on glucose trends and levels is this system. This advancement allowed the business to demonstrate its strong capacity for development.

Insulet Corporation announced that its Omnipod and Omnipod DASH insulin management systems are now FDA-approved for use with Eli Lilly's Lyumjev injectable. The company was able to offer more clinical options for diabetes patients to manage their glucose levels and reduce post-meal increases thanks to FDA approval.

EUROPE TUBELESS INSULIN PUMP MARKETRECENT PARTNERSHIP

A new insulin patch pump called MEDISAFE WF is now possible thanks to a collaboration between a European business and the Terumo Corporation, a manufacturer of medical devices. In order to improve the use of MEDISAFE WITH and normalise insulin pump therapy in patients' daily lives, the agreement was meant to benefit Terumo.

EUROPE TUBELESS INSULIN PUMP MARKETCOMPANY PROFILE

• Insulet Corporation
• Terumo Corporation
• Abbott
• Roche Holding
• Valeritas Holding

THIS REPORT WILL ANSWER FOLLOWING QUESTIONS

1. What is the average cost perEurope tubeless insulin pump marketright now and how will it change in the next 5-6 years?
2. Average cost to set up atubeless insulin pump marketin Europe?
3. How manyEurope tubeless insulin pump marketsare manufactured per annum globally? Who are the sub-component suppliers in different regions?
4. What is happening in the overall public, globally?
5. Cost breakup of aEurope tubeless insulin pump marketand key vendor selection criteria
6. Where is theEurope tubeless insulin pump market manufactured? What is the average margin per equipment?
7. Market share ofEurope tubeless insulin pump marketmanufacturers and their upcoming products
8. The most important plannedEurope tubeless insulin pump marketin next 2 years
9. Details on network of majorEurope tubeless insulin pump marketand pricing plans
10. Cost advantage for OEMs who manufactureEurope tubeless insulin pump marketin-house
11. 5 key predictions for next 5 years inEurope tubeless insulin pump market
12. Average B-2-BEurope tubeless insulin pump marketprice in all segments
13. Latest trends inEurope tubeless insulin pump market, by every market segment
14. The market size (both volume and value) ofEurope tubeless insulin pump marketin 2024-2030 and every year in between?
15. Global production breakup ofEurope tubeless insulin pump market, by suppliers and their OEM relationship